WNBA Sets Groundbreaking Rules for Player Cannabis Endorsements and Investments

The WNBA didn't just remove marijuana from its banned substances list — it wrote the most detailed playbook any major sports league has ever produced for how athletes can participate in the cannabis economy. And buried in the fine print of the new collective bargaining agreement are rules that could reshape the relationship between professional sports and the cannabis industry for years to come.

While other leagues have loosened their cannabis policies in recent years, the WNBA went further by establishing a formal framework governing player investments, endorsements, and promotional activities involving both marijuana and hemp-derived CBD products. It's the first time a major American sports league has explicitly addressed how athletes can make money from cannabis — not just consume it.

What the New Rules Actually Say

The CBA language distinguishes between two categories: marijuana businesses and CBD-only companies. The rules for each are meaningfully different.

Cannabis Investment Rules

Players can hold a direct or indirect ownership interest in marijuana companies, but the agreement imposes three non-negotiable constraints. First, the interest must be entirely passive — no management roles, no board seats, no voting rights, no operational involvement of any kind. Second, the stake must remain below 50 percent of the business. Third, the player must disclose the investment to both the league and the players' union.

This is a carefully calibrated permission. The WNBA wants players to be able to profit from the industry's growth, but it doesn't want active player involvement creating conflicts of interest, regulatory exposure, or PR complications that could reflect on the league.

CBD Endorsement Rules

The rules for CBD companies are notably more permissive. Unlike marijuana businesses, CBD-only companies don't trigger the passive-investment requirement or the 50 percent ownership cap. Players can actively promote and endorse products from companies that exclusively sell CBD.

But there's a critical caveat: if a CBD product is produced or sold by a company that also operates in the marijuana space, the endorsement rules tighten considerably. In that scenario, players need prior written approval from both the WNBA and the Women's National Basketball Players Association before promoting the product.

The logic here reflects the legal patchwork of American cannabis law. CBD derived from hemp is federally legal, while marijuana remains a Schedule III controlled substance at the federal level. The WNBA is drawing a bright line between the two.

The Confusion Test

Perhaps the most interesting provision is what you might call the "confusion test." The CBA states that promotion of CBD products by a marijuana company won't be permitted if the CBD product is "associated with any marijuana product" or if the promotion "creates a reasonable risk of public confusion with any marijuana product."

This means a player couldn't endorse a CBD tincture from a company that sells it alongside THC products under similar branding. The league wants to ensure that CBD endorsements don't serve as backdoor marijuana promotion — a distinction that matters for broadcast partners, sponsors, and the league's federal regulatory posture.

Why This Matters Beyond Basketball

The WNBA's framework is significant for several reasons that extend well beyond the hardwood.

A Template for Other Leagues

The NBA's existing CBA already permits player investment in cannabis companies under similar passive-investment rules. But the WNBA's explicit endorsement framework goes further, creating what could become a template for the NFL, MLB, and NHL as they renegotiate their own agreements. Those leagues have loosened testing but haven't addressed the endorsement question with this level of specificity.

Opening a Revenue Stream for Athletes

WNBA players have historically earned a fraction of their NBA counterparts, which has made endorsement and investment income proportionally more important. Cannabis brands have been actively courting athletes across all major sports, and this framework finally gives WNBA players a clear legal path to participate.

The timing isn't coincidental. The cannabis industry has been eager to associate with professional athletes since the NBA relaxed its own policies, and WNBA players — many of whom have been vocal advocates for cannabis reform — represent an authentic marketing opportunity for brands targeting the growing female cannabis consumer demographic.

The Enforcement Mechanism

The CBA includes teeth. Any investment or promotion that falls outside the permitted boundaries is "prohibited," and the agreement requires that a violating player "promptly dispose of her ownership interest" or "immediately terminate her participation in the prohibited promotion or endorsement." This isn't a suggestion — it's a contractual obligation with real consequences.

Cannabis Still Isn't a Free-for-All

Despite the headline-grabbing removal of marijuana from the banned substances list, the WNBA maintained meaningful guardrails. Players who enter the league's Drugs of Abuse Program can still be tested for cannabis. More importantly, any player found to have been under the influence "while engaged in activities" for the team or the league could face consequences.

The league is drawing a clear distinction: what you do on your own time is your business, but showing up impaired for team activities is still a violation. This mirrors the approach most employers take toward alcohol — legal to consume, prohibited on the job.

The Bigger Picture

The WNBA's move arrives at a pivotal moment for cannabis in professional sports. The NFL stopped suspending players for positive marijuana tests in 2020. The NBA removed cannabis from its banned substances list in 2023. The NHL has never tested for marijuana. And now the WNBA has gone beyond testing policy to address the economic relationship between players and the cannabis industry.

Collectively, these shifts represent a fundamental change in how American sports views cannabis. A substance that ended careers a decade ago is now the subject of detailed investment frameworks designed to help athletes profit from it.

For the cannabis industry, the endorsement rules create a new marketing channel — albeit one with real constraints. Brands that want to work with WNBA players will need to structure their deals carefully, particularly if they operate in both the marijuana and CBD spaces. The confusion test alone will require brands to think more carefully about how they position their product lines.

For fans, the practical impact is more subtle. You're unlikely to see a WNBA player holding up a bag of flower during a press conference. But you might start seeing CBD recovery products with athlete endorsements, carefully structured to stay within the CBA's boundaries. And the players who've quietly held passive stakes in cannabis companies can now do so without worrying about league consequences.

What Comes Next

The real test of these rules will come when the first high-profile endorsement deal is announced. Will the league's approval process be efficient or bureaucratic? Will the confusion test be applied consistently? Will brands structure their corporate entities specifically to qualify under the more permissive CBD-only rules?

These questions will play out over the coming months and years. But for now, the WNBA has done something no other league has attempted: it's built a detailed, workable framework for athletes to participate in the cannabis economy. Whether you're a player, a brand, or a fan, that's a significant shift — and one worth paying attention to.